CPH 0.00% 0.9¢ creso pharma limited

Surprising that no one here commented on this, the single most...

  1. 5,433 Posts.
    lightbulb Created with Sketch. 2140
    Surprising that no one here commented on this, the single most important announcement of the year.

    Did anyone read it? Plenty of holders seem to like talking about this stock but literally no one wanted to comment on the actual figures.

    The salient details burried in the 92 page document...

    The loss in 2018 was $17 million, up $2 million from 2017. Once again, the majority of the money they spent was literally giving it to or spending it on themselves (see page 33 of the report).

    The gross income for 2018 was still just a few hundred thousand dollars.

    A massive increase in liabilities (risk) in 2018 compared to 2019, despite a drop in assets (see page 34 of the report).

    The amount of cash at the start of 2019 was about half of that of the start of 2018 (about $6 million compared to $12 million) despite the capital raising (see page 36). With expenses of over $17 million (most of which goes to themselves) and rising, and sales figures not realistically set to be able to appreciably offset this, it effectively guarantees a capital raising this year which is fair to assume will drop the share price.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.